15.25

2.07% 0.31

After Hours: 15.27 0.02 +0.13%

Bausch Lomb Corp (BLCO)

Overview News Price History Option Chain Financials Discussions Forecast

Bausch Lomb Corp stock is traded at $15.25, with a volume of 361.42K. It is up +2.07% in the last 24 hours and up +0.33% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Previous Close:

$14.94

Open:

$14.93

24h Volume:

361.42K

Relative Volume:

0.65

Market Cap:

$5.40B

Revenue:

$4.89B

Net Income/Loss:

$-263.00M

P/E Ratio:

-19.72

EPS:

-0.7734

Net Cash Flow:

$-167.84M

1W Performance:

-0.78%

1M Performance:

+0.33%

6M Performance:

+32.61%

1Y Performance:

-25.65%

1-Day Range:

$14.60

$15.29

1-Week Range:

$14.60

$16.00

52-Week Range:

$10.45

$20.71

Bausch Lomb Corp Stock (BLCO) Company Profile

Name

Bausch Lomb Corp

Sector

Healthcare (1136)

Industry

Medical Instruments & Supplies (58)

Phone

908-541-5456

Address

520 APPLEWOOD CRESCENT, VAUGHAN

Employee

13,500

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

BLCO's Discussions on Twitter

Compare BLCO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BLCO Bausch Lomb Corp	15.25	5.29B	4.89B	-263.00M	-167.84M	-0.7734
ISRG Intuitive Surgical Inc	544.21	189.40B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	177.30	51.22B	21.39B	1.61B	2.55B	5.5609
ALC Alcon Inc	73.88	36.53B	10.03B	1.07B	1.39B	2.1549
RMD Resmed Inc	248.95	36.04B	5.15B	1.40B	1.65B	9.5082
WST West Pharmaceutical Services Inc	279.78	20.29B	2.96B	487.70M	344.00M	6.6758

Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-01-25	Initiated	Goldman	Neutral
May-02-25	Reiterated	H.C. Wainwright	Buy
Mar-28-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-11-24	Downgrade	Citigroup	Buy → Neutral
Dec-02-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-15-24	Upgrade	Evercore ISI	In-line → Outperform
Jul-10-24	Initiated	Raymond James	Outperform
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line
Dec-12-23	Initiated	Stifel	Hold
Oct-03-23	Resumed	Evercore ISI	Outperform
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight
Sep-12-22	Initiated	H.C. Wainwright	Buy
Jul-26-22	Initiated	RBC Capital Mkts	Outperform
Jun-24-22	Initiated	Evercore ISI	Outperform
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Deutsche Bank	Hold
May-31-22	Initiated	Goldman	Neutral
May-31-22	Initiated	Guggenheim	Buy
May-31-22	Initiated	JP Morgan	Neutral
May-31-22	Initiated	Jefferies	Buy
May-31-22	Initiated	Morgan Stanley	Equal-Weight
May-31-22	Initiated	Wells Fargo	Overweight
May-11-22	Initiated	Cowen	Outperform

View All

Bausch Lomb Corp Stock (BLCO) Latest News

04:35 AM

Bausch + Lomb (NYSE/TSX: BLCO) to hold Investor Day outlining 3-year plan and pipeline - Stock Titan

04:35 AM

09:56 AM

Is Bausch + Lomb Corporation stock safe for conservative investors2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com

09:56 AM

09:16 AM

What margin trends mean for Bausch + Lomb Corporation stock2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com

09:16 AM

08:07 AM

Bausch + Lomb (NYSE:BLCO) Seems To Be Using A Lot Of Debt - 富途牛牛

08:07 AM

02:43 AM

What is the fair value estimate for Bausch + Lomb Corporation (S2L) stock in 2025Fed Meeting & Risk Managed Investment Entry Signals - newser.com

02:43 AM

02:25 AM

Q4 EPS Estimates for Bausch + Lomb Raised by HC Wainwright - MarketBeat

02:25 AM

Nov 02, 2025

How strong is Bausch + Lomb Corporation stock revenue growthChart Signals & Stock Timing and Entry Methods - newser.com

Nov 02, 2025

Real time breakdown of Bausch + Lomb Corporation stock performance2025 Sector Review & Weekly High Conviction Ideas - newser.com

Nov 02, 2025

Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Nov 02, 2025

Nov 01, 2025

Forecasting Bausch + Lomb Corporation price range with options dataOptions Play & Step-by-Step Trade Execution Guides - newser.com

Nov 01, 2025

Oct 31, 2025

Using data models to predict Bausch + Lomb Corporation stock movementJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com

Oct 31, 2025

Bausch + Lomb (BLCO) Net Losses Deepen 53.3% Annually Despite Turnaround Hopes - Sahm

Oct 31, 2025

Bausch + Lomb (NYSE:BLCO) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Oct 31, 2025

Bausch + Lomb's (BLCO) Outperform Rating Reaffirmed at Raymond James Financial - MarketBeat

Oct 31, 2025

A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $16 to $17 - 富途牛牛

Oct 31, 2025

7 Analysts Have This To Say About Bausch & Lomb - Benzinga

Oct 31, 2025

Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $17 - 富途牛牛

Oct 31, 2025

Why Bausch + Lomb Corporation stock could see breakout soonWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com

Oct 31, 2025

Oct 30, 2025